|
FTH Faeth Therapeutics, Inc 1829802 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-16,007,000.00 |
| Balance Sheet |
|
Current Assets
|
$188,658,000.00 |
|
Assets
|
$189,306,000.00 |
|
Current Liabilities
|
$9,580,000.00 |
|
Liabilities
|
$9,581,000.00 |
|
Equity
|
$172,958,000.00 |
|
Shares Out
|
25832969.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-26,406,000.00 |
|
Investing Cash Flow
|
$-139,502,000.00 |
| Market Analysis |
Market Cap
|
$829,238,304.90 |
|
Price
|
$34.50 |
|
BVPS
|
6.70 |
|
PB
|
4.79 |
|
EPS
|
-2.84 |
|
FCF
|
$-26,412,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:09 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:58 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FTH documents filed with the SEC.
FTH Filings
Clear
